Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Skin sterol study

This article was originally published in The Tan Sheet

Executive Summary

People with high levels of skin tissue cholesterol and C-reactive protein have nearly double the risk of metabolic syndrome compared to those without elevated levels of both markers, according to data presented by PreMD at the American Heart Association's Annual Arteriosclerosis, Thrombosis & Vascular Biology conference in Toronto April 27. The study used PREVU* Point Of Care Skin Sterol Test to measure skin sterol and C-reactive protein levels in 301 patients with established coronary artery disease to assess whether the two markers could help predict metabolic syndrome. "The prevalence of metabolic syndrome in was significantly higher in patients who scored highest for both skin sterol and C-reactive protein, and remained significant after adjustment for age and gender, compared to isolated elevators of either marker alone," Milan Gupta, MD, McMaster University, Ontario, et al., state. PreMD is currently investigating a home-use version of the PREVU* test, which is currently designed for use by medical professionals. However, the home-use product has not yet entered the clinical stage, a spokesperson says...

You may also be interested in...



Vaccine Company CEOs Face Supply Probe In EU

AstraZeneca's CEO and other leaders from COVID-19 vaccine companies will face some tough questions in Brussels, but the European Commission wants to put differences behind it and solve the vaccine supply problem as soon as possible.

Trial Shows Lateral Flow Antibody Testing Could Be Used To Assess COVID-19 Vaccine Efficacy

Abingdon Health has announced that a study run in conjunction with the UK Rapid Test Consortium has demonstrated that its AbC-19 test could be an effective tool for testing vaccine efficacy. 

CIR ‘Watchdog’ Women’s Voices For The Earth To Remain On Guard In 2021

NGO says the Expert Panel for Cosmetic Ingredient Safety’s conclusion on methylisothiazolinone in 2020 was among decisions “not in the interest of public health.” However, other assessments highlighted by the group suggest that the Cosmetic Ingredient Review is working as an open forum for public input and discussion.

Topics

UsernamePublicRestriction

Register

OM017301

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel